Trademark: 79139640
Word
A
Status Date
Monday, August 30, 2021
Registration Number
4619191
Registration Date
Tuesday, October 14, 2014
Filing Date
Wednesday, October 16, 2013
Published for Opposition
Tuesday, July 29, 2014
9 [ Measuring apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometry analyzers for cellular analysis; scientific, optical, measuring, signaling and checking apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometers for single cell and population based cellular analysis; measuring and testing machines and instruments, namely, protein separation and isolation instruments, flow cytometers, and laboratory liquid handlers and automation for testing and implementing cellular based screening methods; laboratory apparatus and instruments for use in growing, maintaining, evaluating and quality control of cell cultures, automated liquid dispensing, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purposes; chemistry apparatus and instruments for maintaining, evaluating and quality control of cell cultures, automated liquid dispensing of compound preparations and chemical reagents, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purpose ]
5 [ In vitro diagnostic preparations for medical use; diagnostic test reagents for medical use; chemical reagents for medical or veterinary use; diagnostic reagents and contrast media agents for medical use; Medical diagnostic reagents; Reagents for medical use ]
42 Scientific research and development; scientific and technological services, namely, novel multi-parametric phenotypic screening in the nature of analytical testing services and protein isolation for the characterization and simultaneous identification of multiple biological and physiological effects caused by drug candidates on live human cell models in the field of pharmaceutical research, drug discovery and characterization of compound effect, and scientific research and development relating thereto; Scientific and technological services for scientific analysis, testing and research in the fields of pharmaceutical research, [ drug discovery and characterization of compound effect, and protein separation, isolation and characterization; ] scientific research services; scientific testing and analysis in the fields of pharmaceutical research, [ drug discovery and characterization of compound effect, and protein separation, isolation and characterization; ] computer-assisted scientific research, testing and analysis services in the fields of pharmaceutical research, drug discovery and characterization of compound effect by using mathematical and statistical algorithms to compare and predict the effect of a target compound to that of an approved drug or known toxin, where a biological fingerprint is created and analyzed by measuring the broad physiological and biological effect of said compounds on live human cells; laboratory research and analysis services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; pharmaceutical research and development; ] Scientific research and scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific laboratory services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery [ and characterization of chemical compounds, and protein separation, isolation and characterization; provision of information about medical and scientific research in the field of pharmaceuticals; preparation of reports on scientific research ]; provision of scientific information on technological research in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; [ provision of scientific information about industrial analysis and research services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; provision of information and data relating to medical research and development and veterinary medical research; consultancy services in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics; engineering and ] scientific consultancy services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds [, and protein separation, isolation and characterization; provision of technical advice in the field of scientific and industrial research; consultancy in the field of scientific and industrial research ]
The mark consists of the letter "A" formed by three oblong shapes.
Color is not claimed as a feature of the mark.
Oct 14, 2023
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Sep 29, 2023
International Registration Renewed
Jun 7, 2023
Limitation From The Ib Examined, No Action Is Needed
Mar 27, 2023
Limitation Of Goods Received From Ib
Sep 20, 2022
Partial Invalidation Processed By The Ib
Aug 3, 2022
Partial Invalidation Of Reg Ext Protection Sent To Ib
Aug 3, 2022
Invalidation Processed
Apr 30, 2022
Partial Invalidation Of Reg Ext Protection Created
Aug 30, 2021
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
Aug 30, 2021
Registered - Partial Sec. 71 Accepted & Sec. 15 Ack.
Aug 27, 2021
Case Assigned To Post Registration Paralegal
Apr 14, 2021
Teas Section 71 & 15 Received
Oct 14, 2019
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Apr 24, 2015
Final Decision Transaction Processed By Ib
Mar 11, 2015
Final Disposition Notice Sent To Ib
Mar 11, 2015
Final Disposition Processed
Jan 14, 2015
Final Disposition Notice Created, To Be Sent To Ib
Oct 14, 2014
Registered-Principal Register
Jul 31, 2014
Change Of Name/Address Rec'd From Ib
Jul 29, 2014
Official Gazette Publication Confirmation E-Mailed
Jul 29, 2014
Published For Opposition
Jul 24, 2014
Notification Processed By Ib
Jul 9, 2014
Notification Of Possible Opposition Sent To Ib
Jul 9, 2014
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jul 9, 2014
Notification Of Notice Of Publication E-Mailed
Jun 26, 2014
Law Office Publication Review Completed
Jun 25, 2014
Assigned To Lie
Jun 9, 2014
Approved For Pub - Principal Register
Jun 9, 2014
Examiner's Amendment Entered
Jun 9, 2014
Notification Of Examiners Amendment E-Mailed
Jun 9, 2014
Examiners Amendment E-Mailed
Jun 9, 2014
Examiners Amendment -Written
Mar 4, 2014
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 4, 2014
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 22, 2014
Refusal Processed By Ib
Feb 6, 2014
Non-Final Action Mailed - Refusal Sent To Ib
Feb 6, 2014
Refusal Processed By Mpu
Feb 6, 2014
Non-Final Action (Ib Refusal) Prepared For Review
Feb 5, 2014
Non-Final Action Written
Jan 31, 2014
Assigned To Examiner
Dec 17, 2013
Application Filing Receipt Mailed
Dec 13, 2013
New Application Office Supplied Data Entered
Dec 12, 2013
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
